论文部分内容阅读
肺胞内分支菌病(以下简称肺胞内菌病)是肺非典型抗酸菌病中的一种,由胞内分支菌感染引起的肺部病变。国外对本病已有不少报导,国内尚缺少报导。我所自1980年迄今,在1200例肺结核患者中确诊为本病者共7例,均误诊为肺结核病。现将其细菌学和临床资料分析如下。一、诊断依据: 1.从患者痰中多次涂片找到和培养出抗酸杆菌,并经菌型鉴定为胞内分支菌达4次以上,其中最少要有1次菌落在100个以上。 2.菌株对大多数抗结核药物有不同程度的耐药性,且临床应用多无效或效果差。 3.有与该病相应的症状和病变。
Pulmonary intracellular mycosis (hereinafter referred to as pulmonary intracellular mycosis) is one of the atypical acid-fast bacilli in the lung, caused by intra-cellular mycobacterial infection caused by lung lesions. There are many foreign reports on the disease, but there are still a few reports in the country. Since 1980, I have diagnosed a total of 7 patients with this disease in 1200 cases of pulmonary tuberculosis, which were all misdiagnosed as pulmonary tuberculosis. Now bacteriological and clinical data analysis is as follows. First, the diagnosis is based on: 1. Sputum sputum from patients found and cultivated several acid-fast bacilli, and identified as mycobacteria by intracellular mycobacterial up to 4 times, of which at least one colony in 100 or more. 2. strains of most of the anti-TB drugs have different degrees of resistance, and clinical application of multiple or ineffective. 3. There are symptoms and lesions corresponding to the disease.